bcnu
Showing 1 - 16 of 16
Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)
Recruiting
- Non-Hodgkin Lymphoma
- Hodgkin Lymphoma
- Etoposide
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jan 25, 2023
Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)
Recruiting
- Pancreatic Adenocarcinoma Metastatic
- +14 more
- Melphalan
- +5 more
-
Boston, Massachusetts
- +1 more
Dec 6, 2022
Leukemia, Lymphoma, Non-Hodgkin, Hematologic Diseases Trial in Stanford (Sirolimus, MMF, BCNU)
Completed
- Leukemia
- +3 more
- Sirolimus
- +6 more
-
Stanford, CaliforniaStanford University School of Medicine
Sep 16, 2021
Lymphoma, HIV Trial in United States (Autologous transplant, BCNU, Etoposide)
Completed
- Lymphoma
- HIV
- Autologous transplant
- +4 more
-
Duarte, California
- +15 more
Dec 6, 2022
Lymphoma, Leukemia Trial in Houston (drug, other, radiation, procedure)
Lymphoma, Hodgkin's Disease Trial in Houston (Melphalan, Ara-C, VP-16)
Lymphoma, Non-Hodgkin Trial in Stanford (Cyclophosphamide, BCNU, Etoposide)
Terminated
- Lymphoma, Non-Hodgkin
- Cyclophosphamide
- +12 more
-
Stanford, CaliforniaStanford University School of Medicine
Jan 17, 2018
CNS Lymphoma Trial in Worldwide (drug, radiation, other)
Completed
- Central Nervous System Lymphoma
- Methotrexate
- +6 more
-
Aachen, Germany
- +22 more
Aug 22, 2017
Leukemia, Multiple Myeloma Trial in Stanford (CIK cells, etoposide, bcnu)
Completed
- Leukemia
- Multiple Myeloma
- CIK cells
- +6 more
-
Stanford, CaliforniaStanford University School of Medicine
Jan 9, 2017
Multiple Myeloma Trial in Little Rock (Thalidomide, Ara-C, BCNU)
Completed
- Multiple Myeloma
- Thalidomide
- +12 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences/MIRT
Oct 21, 2015
Lymphoma Trial in Houston (Y Zevalin, In Zevalin, Rituxan)
Completed
- Lymphoma
- Y Zevalin
- +8 more
-
Houston, TexasUT MD Anderson Cancer Center
Sep 4, 2014
Lymphoma Trial in Houston (Campath-1H, G-CSF, GM-CSF)
DLBCL, IPI=2 Trial in Italy (Rituximab, Ciclofosfamide, Doxorubicina)
Unknown status
- Diffuse Large B-Cell Lymphoma
- IPIā„2
- Rituximab
- +11 more
-
Nocera Inferiore, Salerno, Italy
- +74 more
Feb 14, 2011